Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Orchard Therapeutics plc (ORTX)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Jun-05-23Mar-31-23Mar-05-23Dec-31-22Dec-05-22Sep-30-22Jun-30-22
   10-Q8-K10-Q8-K10-K8-K10-Q10-Q
Net income  -12.30.0-17.4-17.4-7.9-7.9-47.6-50.9
Depreciation and amortization   [+]0.7 0.6 0.7 0.70.7
Change in working capital      34.3   
Other operating activities  -16.2 -12.7 -39.3 29.023.9
Cash from operations  -27.8 -29.5 -12.1 -17.9-26.4
   
Capital expenditures  0.0 0.5 0.5 4.51.2
Purchases of short-term investments  75.7 38.8 41.1 20.321.2
Other cash from investing  -102.4 -48.7 -43.1 22.6-2.7
Cash from investing  -26.7 -9.3 -1.6 47.419.6
   
Option exercises  0.2 0.0 0.1 0.00.1
Other cash from financing  31.1 31.5 -0.7 0.00.3
Cash from financing  30.9 31.5 -0.8 0.00.1
   
Free cash flow  -27.9 -29.0 -11.6 -13.5-25.2
        Per share (diluted)  ($0.15) ($0.20) ($0.09) ($0.11)($0.20)
   
Cash paid for interest  0.8 0.8 0.8 0.70.6

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy